Summary:
- This article discusses Alector, a biopharmaceutical company focused on developing therapies for neurodegenerative diseases.
- Alector is working on treatments that target the immune system to address the underlying causes of Alzheimer's, Parkinson's, and other brain disorders.
- The company is using its proprietary platform to identify and develop novel therapeutic candidates that have the potential to slow or halt the progression of these devastating diseases.